Skip to main
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 33%
Hold 42%
Sell 0%
Strong Sell 0%

Bulls say

Revvity's stock outlook is bolstered by its strategic transition from TST to IGRA testing, which is projected to enhance market growth by several hundred basis points annually. The company benefits from a diversified portfolio that includes a high-growth software solution (Signals) and a strong presence in life sciences and immunodiagnostics, which collectively drive above-market growth and improve overall profitability. As Revvity continues to enhance its competitive position, particularly in the US market through share gains in autoimmune testing, its financial profile is expected to further strengthen due to improved margins and operating efficiencies.

Bears say

Revvity's financial outlook appears negative due to significant challenges in its China market, with total revenues from this region expected to decline to approximately 7% of total revenue by 2025, alongside Immunodiagnostics revenue projected to fall below 5% by 2026. The company faces headwinds from poor economic conditions and cuts to industry funding, which are likely to slow customer demand for its products and services, subsequently impacting growth and market share. Additionally, macroeconomic changes may disrupt Revvity's supply chain, leading to product shortages, inflationary pressures, transit delays, and labor shortages that could hinder operational efficiency and performance.

Revvity Inc (RVTY) has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 33% recommend Buy, 42% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Buy based on their latest research and market trends.

According to 12 analysts, Revvity Inc (RVTY) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $112.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $112.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.